The vaccine is from Serum and was around 90% effective against symptomatic cases in adults, in addition to having logistical advantages; The goal is to distribute up to 5 million doses by the end of December
The Ministry of Health recently announced the distribution of 1.5 million doses of the vaccine against expected to be delivered by Tuesday (10). The vaccines, developed by the pharmaceutical company Serum, will be sent to Brazilian states for the first time. According to the ministry, the vaccine demonstrated around 90% efficacy against symptoms and symptomatic cases in adults during phase three of clinical studies. Furthermore, the vaccine has significant logistical advantages, such as ease of transportation and conservation, which facilitates its large-scale distribution.
In addition to immediate distribution, the has ambitious plans for the near future. The ministry intends to distribute 5 million doses by the end of December, as part of a larger batch of 8 million doses that will be delivered over the next six months. In the last trading session, the ministry purchased 69 million doses, guaranteeing the country’s supply for the next two years. Deliveries will be made in installments, according to the population’s adherence to vaccination, which will allow for more efficient management of stocks.
This intensification in the distribution of vaccines occurs in response to complaints and reports that highlighted the lack of vaccines in several regions of the country. Despite the complaints, the Minister of Health, Nísia Trindade, denies that there are supply problems. However, the intensified vaccine distribution aims to address these concerns and ensure that the population has access to necessary immunization.
*With information from Camila Yunes
*Report produced with the help of AI
